Pharmacist’s Suspension Extended After Dishonesty in Taking Returned Medications

Date of Decision: February 16, 2016

Registrant's Role: Pharmacist

Allegations:

  • The pharmacist dishonestly removed unspecified quantities of four medications (three prescription-only medicines and one over-the-counter analgesic) from patient-returned stock at his workplace.
  • The misconduct occurred over two years (April 2011 – May 2013).
  • The pharmacist voluntarily disclosed his actions to his employer’s Revenue Protection Officer during an unrelated internal investigation.
  • The GPhC found his conduct dishonest, bringing the profession into disrepute and calling into question his integrity.
  • A nine-month suspension was imposed in May 2015, with a review hearing scheduled before reinstatement.
  • The pharmacist failed to provide evidence of insight, remorse, or remediation

Outcome: A six-month extension of the suspension was imposed

GPhC Standards Breached:

  • Standard 2 – Work in Partnership with Others
  • Standard 4 – Maintain, Develop, and Use Professional Knowledge and Skills
  • Standard 6 – Behave in a Professional Manner
  • Standard 9 – Demonstrate Leadership

Case Summary

The General Pharmaceutical Council (GPhC) Fitness to Practise Committee investigated a pharmacist who dishonestly removed medications from his workplace over a two-year period.

Between April 2011 and May 2013, the pharmacist took prescription-only and over-the-counter medicines from patient-returned stock for his personal use. The medicines were not taken from new stock, and there was no evidence of resale or patient harm.

However, his dishonesty came to light when he voluntarily disclosed his actions to a Revenue Protection Officer at Lloyds Pharmacy during an unrelated internal investigation. This led to an employer-led investigation and subsequent referral to the GPhC.

Continue Reading the Full Case

Create a free account or log in to access the complete case summary.

  • Full allegations considered by the GPhC
  • Panel findings and reasoning
  • Outcome of the investigation
  • Sanctions considered and imposed on the Pharmacist
  • Key professional learning points

Register for Free or Log In

Note: The original PDF document is not available for this case.

Leave a Reply